Literature DB >> 15138199

Clinical implications of E-cadherin associated hereditary diffuse gastric cancer.

R C Fitzgerald1, C Caldas.   

Abstract

Approximately 1-3% of gastric cancers arise as a result of inherited gastric cancer predisposition syndromes. These may be of the diffuse or intestinal type. Linkage analysis has recently implicated E-cadherin mutations in an estimated 25% of families with an autosomal dominant predisposition to diffuse type gastric cancers. This subset of gastric cancer has been termed hereditary diffuse gastric cancer (HDGC).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138199      PMCID: PMC1774077          DOI: 10.1136/gut.2003.022061

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  36 in total

1.  E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.

Authors:  J C Machado; P Soares; F Carneiro; A Rocha; S Beck; N Blin; G Berx; M Sobrinho-Simões
Journal:  Lab Invest       Date:  1999-04       Impact factor: 5.662

Review 2.  The recognition and endoscopic treatment of early gastric and colonic cancer.

Authors:  B Rembacken; T Fujii; H Kondo
Journal:  Best Pract Res Clin Gastroenterol       Date:  2001-04       Impact factor: 3.043

Review 3.  Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?

Authors:  Y S Chun; N M Lindor; T C Smyrk; B T Petersen; L J Burgart; P J Guilford; J H Donohue
Journal:  Cancer       Date:  2001-07-01       Impact factor: 6.860

Review 4.  Familial gastric cancer: overview and guidelines for management.

Authors:  C Caldas; F Carneiro; H T Lynch; J Yokota; G L Wiesner; S M Powell; F R Lewis; D G Huntsman; P D Pharoah; J A Jankowski; P MacLeod; H Vogelsang; G Keller; K G Park; F M Richards; E R Maher; S A Gayther; C Oliveira; N Grehan; D Wight; R Seruca; F Roviello; B A Ponder; C E Jackson
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

5.  Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.

Authors:  D G Huntsman; F Carneiro; F R Lewis; P M MacLeod; A Hayashi; K G Monaghan; R Maung; R Seruca; C E Jackson; C Caldas
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

6.  Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer.

Authors:  W M Grady; J Willis; P J Guilford; A K Dunbier; T T Toro; H Lynch; G Wiesner; K Ferguson; C Eng; J G Park; S J Kim; S Markowitz
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

7.  A germline E-cadherin mutation in a family with gastric and colon cancer.

Authors:  S Salahshor; H Hou; C B Diep; A Loukola; H Zhang; T Liu; J Chen; L Iselius; C Rubio; R A Lothe; L Aaltonen; X F Sun; G Lindmark; A Lindblom
Journal:  Int J Mol Med       Date:  2001-10       Impact factor: 4.101

8.  E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer.

Authors:  P J Guilford; J B Hopkins; W M Grady; S D Markowitz; J Willis; H Lynch; A Rajput; G L Wiesner; N M Lindor; L J Burgart; T T Toro; D Lee; J M Limacher; D W Shaw; M P Findlay; A E Reeve
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

9.  Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.

Authors:  F M Richards; S A McKee; M H Rajpar; T R Cole; D G Evans; J A Jankowski; C McKeown; D S Sanders; E R Maher
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

10.  Prophylactic total gastrectomy for familial gastric cancer.

Authors:  F R Lewis; J D Mellinger; A Hayashi; D Lorelli; K G Monaghan; F Carneiro; D G Huntsman; C E Jackson; C Caldas
Journal:  Surgery       Date:  2001-10       Impact factor: 3.982

View more
  30 in total

Review 1.  Recognition of and recent issues in hereditary diffuse gastric cancer.

Authors:  Shinya Sugimoto; Hirokazu Komatsu; Yuichi Morohoshi; Takanori Kanai
Journal:  J Gastroenterol       Date:  2015-06-07       Impact factor: 7.527

2.  Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.

Authors:  Kristy Lee; Kate Krempely; Maegan E Roberts; Michael J Anderson; Fatima Carneiro; Elizabeth Chao; Katherine Dixon; Joana Figueiredo; Rajarshi Ghosh; David Huntsman; Pardeep Kaurah; Chimene Kesserwan; Tyler Landrith; Shuwei Li; Arjen R Mensenkamp; Carla Oliveira; Carolina Pardo; Tina Pesaran; Matthew Richardson; Thomas P Slavin; Amanda B Spurdle; Mackenzie Trapp; Leora Witkowski; Charles S Yi; Liying Zhang; Sharon E Plon; Kasmintan A Schrader; Rachid Karam
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

3.  Risk and characteristics of gastric carcinoma in the chow chow dog.

Authors:  Amy M Koterbay; Sureshkumar Muthupalani; James G Fox; Elizabeth A McNiel
Journal:  Can Vet J       Date:  2020-04       Impact factor: 1.008

4.  Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family.

Authors:  Carla Oliveira; Herculano Moreira; Raquel Seruca; Manuel Cardoso de Oliveira; Fátima Carneiro
Journal:  Virchows Arch       Date:  2004-12-11       Impact factor: 4.064

5.  Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance?

Authors:  Takeshi Nakajima; Ichiro Oda; Takuji Gotoda; Hisanao Hamanaka; Takako Eguchi; Chizu Yokoi; Daizo Saito
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

Review 6.  Hereditary diffuse gastric cancer: What the clinician should know.

Authors:  Ryan Ying Cong Tan; Joanne Ngeow
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

7.  Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.

Authors:  Krishna S Gunturu; Yanghee Woo; Nike Beaubier; Helen E Remotti; M Wasif Saif
Journal:  Ther Adv Med Oncol       Date:  2013-03       Impact factor: 8.168

Review 8.  Preemptive surgery for premalignant foregut lesions.

Authors:  Rohit R Sharma; Mark J London; Laura L Magenta; Mitchell C Posner; Kevin K Roggin
Journal:  J Gastrointest Surg       Date:  2009-06-10       Impact factor: 3.452

9.  Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC).

Authors:  Carla Oliveira; Raquel Seruca; Nicoline Hoogerbrugge; Marjolijn Ligtenberg; Fátima Carneiro
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

10.  Single-bite versus double-bite technique for mapping biopsies during endoscopic surveillance for hereditary diffuse gastric cancer: a single-center, randomized trial.

Authors:  Apostolos Pappas; Wei Keith Tan; William Waldock; Susan Richardson; Monika Tripathi; Wladyslaw Januszewicz; Geoffrey Roberts; Maria O'Donovan; Rebecca C Fitzgerald; Massimiliano di Pietro
Journal:  Endoscopy       Date:  2020-07-17       Impact factor: 10.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.